Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep255 | Calcium and Bone | ECE2024

An interesting case of co-existence of autosomal dominant hypocalcemia 1 with chronic myelogenous leukemia

Eleni Chondrogianni Maria , Kyrou Ioannis , Papadopoulou Anna , Kaperda Aikaterini , Diamantopoulos Panagiotis , Angelousi Anna , Randeva Harpal , Kassi Eva

Introduction: Autosomal dominant hypocalcemia (ADH) type 1 is a rare form of hypoparathyroidism, caused by heterozygous, inherited or de novo, activating mutations in the CASR. CASR is also expressed in the kidney and activating mutations lead to decreased calcium renal absorption. Activating mutations in the CasR, inhibits salt transport, leading to Bartteŕs syndrome (BS) type V which can co-exist with ADH1. Chronic myeloid leukemia (Cml) is characterized by the...

ea0099ep142 | Endocrine-Related Cancer | ECE2024

Magnetic resonance imaging in patients with immune check point inhibitors induced hypophysitis

Karampela Athina , Angelousi Anna , Savelli Akrivi , Papalexis Petros , Siampanopoulou Vasiliki , Lafioniatis Alexandros-Aristeidis , Leontari Ekaterini , Diamantopoulos Panagiotis , Gogas Helen

Introduction: Immune checkpoint inhibitors (ICIs), are widely used as therapeutic option in oncological patients. However, ICIs treatment is often complicated by endocrinological adverse events, such as hypophysitis. Although diagnostical approach of hypophysitis is standardized, imaging features have not been characterized yet. Methods: Pituitary gland magnetic resonance imaging (MRI) findings were retrospectively recorded in 59 oncological patients wit...